Jefferies Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-21,600
Closed -$1.98M 1925
2021
Q4
$1.98M Buy
+21,600
New +$2.58M 0.01% 788
2021
Q3
Sell
-44,000
Closed -$7.32M 2014
2021
Q2
$7.32M Buy
+44,000
New +$7.13M 0.05% 352
2021
Q1
Sell
-2,500
Closed -$500K 1986
2020
Q4
$500K Buy
+2,500
New +$508K ﹤0.01% 1134
2020
Q2
Sell
-189,800
Closed -$29.4M 1999
2020
Q1
$29.4M Sell
189,800
-313,000
-62% -$36.4M 0.33% 40
2019
Q4
$42.1M Buy
502,800
+288,600
+135% +$22M 0.33% 45
2019
Q3
$14.5M Buy
+214,200
New +$14.1M 0.11% 128
2019
Q1
Sell
-37,000
Closed -$1.83M 2623
2018
Q4
$1.83M Buy
37,000
+10,400
+39% +$636K 0.01% 858
2018
Q3
$2.3M Buy
+26,600
New +$1.9M 0.02% 910

Other funds holding TDOC

Jefferies Group's TDOC Position: Q3 2022 in Review

Jefferies Group sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 8,000 shares — an estimated $266K sold.

Jefferies Group first reported a position in TDOC in Q3 2016 and held it in 19 quarters. The position peaked at $22.5M in Q4 2019. 482 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Jefferies Group reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Jefferies Group sold 8,000 Teladoc Health shares in Q3 2022, an estimated $266K.
  • Jefferies Group first reported a position in Teladoc Health in Q3 2016 and held it in 19 quarters.
  • Jefferies Group's Teladoc Health position peaked at $22.5M in Q4 2019.
  • 482 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.